Public listed companies - Open Access .click

Results 191 to 200 of about 13,193,410 (237)

The future of scholarly blogs: Scholarly bloggers' perspectives on long‐term preservation

Journal of the Association for Information Science and Technology, EarlyView.
Abstract Scholarly blogs are an important venue for scholarly communication; however, they are not yet integrated into the preservation workflows of digital research and information infrastructures, which places their long‐term access at risk. By using Star and Ruhleder's (1996) dimensions of information infrastructure as a theoretical framework, in ...
Catharina Ochsner, Heinz Pampel
wiley +1 more source

Assessing the investment risk: An empirical analysis of Altman's Z-score model. [PDF]

PLoS One
Ahmed KA, Fatima A, Sohail F, Jamal K.
europepmc +1 more source

A sustainable business ecosystem: a case study demonstrating biochar's potential

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract The need for renewable, climate‐friendly resources has become urgent as legislators worldwide have sought to find ways to cut emissions while ensuring resource security for consumers. The use of biochar could help to achieve these goals. This study examines the current state of commercial biochar production and the maturity of the related ...
Juuso Kivijakola +4 more
wiley +1 more source

From words to action? Linking ESG reports to environmental performance. [PDF]

PLoS One
Savin I, Carel ML, Schlindwein E.
europepmc +1 more source

Driving continuous improvement of sustainability certification for industrial biobased systems through comprehensive sustainability requirements

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Existing monitoring frameworks for sustainability certification schemes and labels (CSLs) have largely prioritised environmental aspects, while the social and economic pillars of sustainability remain comparatively underdeveloped. Also, dedicated circularity requirements tailored to biobased systems are still largely lacking, despite being ...
Iris Vural Gursel +5 more
wiley +1 more source

Promote or prevent? A regulatory focus perspective on managerial risk taking. [PDF]

PLoS One
Miązek AJ, Światowiec-Szczepańska J.
europepmc +1 more source

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

British Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley +1 more source

Trends in nephrology: from MANELS to a balanced representation of all community members. [PDF]

Nephrol Dial Transplant
Del Vecchio L, Women of ERA (WERA) Committee. +1 more
europepmc +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source

corporate governance
financial distress
corporate social responsibility

public ownership